Hostname: page-component-76fb5796d-5g6vh Total loading time: 0 Render date: 2024-04-27T00:21:12.671Z Has data issue: false hasContentIssue false
  • English
  • Français

Applying developmental programming to clinical obstetrics: my ward round

Part of: Sir David Barker Symposium

Published online by Cambridge University Press:  13 May 2015

R. C. Painter
R. C. Painter*
Affiliation:
Department of Obstetrics and Gynaecology, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands
*
*Address for correspondence: R. Painter, Department of Obstetrics and Gynaecology, Academic Medical Centre, Meibergdreef 9, Amsterdam, 1105 AZ, The Netherlands. (Email r.c.painter@amc.uva.nl)
Get access Rights & Permissions [Opens in a new window]

Abstract

The theory of developmental programming is supported by accumulating evidence, both observational and experimental. The direct application of the principles of developmental programming by clinicians to benefit pregnant women remains an area of limited attention. Examining a selection of inpatients at an obstetric referral center, I searched for situations in which clinical decision making could be driven by the principles of developmental programming. I also looked for situations in which the clinical research agenda could be dictated by these concepts. In the decision to undertake preventive measures to avoid preeclampsia, the offspring’s perspective may support more liberal application of calcium and aspirin. Consideration of the long-term health perspective of the offspring could drive choices in the management of obesity and diabetes in pregnancy. The administration of corticosteroids in women delivering by elective cesarean at term may have modest short-term benefits, but additional trials are necessary to investigate long-term offspring health. The offspring of women suffering hyperemesis gravidarum may benefit from nutritional therapy. The long-term health of the offspring could affect couples’ choice for IVF or expectant management. Applying the principles of developmental programming to the management of pregnant women could drive clinical decision making and is driving the clinical research agenda. Increasingly, developmental programming concepts are becoming an integral part of clinical practice, as well as determining the choice of outcomes in trials in obstetrics and fertility medicine. The presented cases underscore the need for more research to guide clinical practice.

Keywords

humanpregnancyoffspring
Type
Original Article
Information
Journal of Developmental Origins of Health and Disease , Volume 6 , Issue 5: Themed Issue: David Barker commemorative meeting, September 2014; Prenatal Exposures and Health Outcomes , October 2015 , pp. 407 - 414
Check for updates
Copyright
© Cambridge University Press and the International Society for Developmental Origins of Health and Disease 2015 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Bateson, P, Barker, D, Clutton-Brock, T, et al. Developmental plasticity and human health. Nature. 2004; 430, 419–421.Google Scholar
2. Whincup, PH, Kaye, SJ, Owen, CG, et al. Birth weight and risk of type 2 diabetes: a systematic review. JAMA. 2008; 300, 2886–2897.Google ScholarPubMed
3. Nutrition(SCN) UnSCo. 5th Report on the World Nutrition Situation: Nutrition for Improved Development Outcomes-March 2004, Geneva. 2004; pp. 1–148.Google Scholar
4. UNICEF. Tracking progress on child and maternal nutrition – a survival and development priority. 2009 United Nations Children’s Fund (UNICEF): New York. 119pp.Google Scholar
5. 1,000 Days [http://www.thousanddays.org/].Google Scholar
6. Kenyon, S, Brocklehurst, P, Jones, D, et al. MRC ORACLE Children Study. Long term outcomes following prescription of antibiotics to pregnant women with either spontaneous preterm labour or preterm rupture of the membranes. BMC Pregnancy Childbirth. 2008; 8, 14.Google Scholar
7. Doyle, LW, Crowther, CA, Middleton, P, Marret, S, Rouse, D. Magnesium sulphate for women at risk of preterm birth for neuroprotection of the fetus. Cochrane Database Syst Rev. 2009; CD004661.Google Scholar
8. Geelhoed, JJ, Fraser, A, Tilling, K, et al. Preeclampsia and gestational hypertension are associated with childhood blood pressure independently of family adiposity measures: the Avon Longitudinal Study of Parents and Children. Circulation. 2010; 122, 1192–1199.Google Scholar
9. Mamun, AA, Kinarivala, MK, O'Callaghan, M, et al. Does hypertensive disorder of pregnancy predict offspring blood pressure at 21 years? Evidence from a birth cohort study. J Hum Hypertens. 2012; 26, 288–294.Google Scholar
10. Jayet, PY, Rimoldi, SF, Stuber, T, et al. Pulmonary and systemic vascular dysfunction in young offspring of mothers with preeclampsia. Circulation. 2010; 122, 488–494.Google Scholar
11. Kent, AL, Chaudhari, T. Determinants of neonatal blood pressure. Curr Hypertens Rep. 2013; 15, 426–432.Google Scholar
12. Kajantie, E, Eriksson, JG, Osmond, C, Thornburg, K, Barker, DJ. Pre-eclampsia is associated with increased risk of stroke in the adult offspring: the Helsinki birth cohort study. Stroke. 2009; 40, 1176–1180.Google Scholar
13. Tuovinen, S, Raikkonen, K, Pesonen, AK, et al. Hypertensive disorders in pregnancy and risk of severe mental disorders in the offspring in adulthood: the Helsinki Birth Cohort Study. J Psychiatr Res. 2012; 46, 303–310.Google Scholar
14. Tuovinen, S, Raikkonen, K, Kajantie, E, et al. Depressive symptoms in adulthood and intrauterine exposure to pre-eclampsia: the Helsinki Birth Cohort Study. BJOG. 2010; 117, 1236–1242.Google Scholar
15. Tuovinen, S, Eriksson, JG, Kajantie, E, Raikkonen, K. Maternal hypertensive pregnancy disorders and cognitive functioning of the offspring: a systematic review. J Am Soc Hypertens. 2014; 8, 832.e1–847.e1.Google Scholar
16. Ahmed, R, Dunford, J, Mehran, R, Robson, S, Kunadian, V. Pre-eclampsia and future cardiovascular risk among women: a review. J Am Coll Cardiol. 2014; 63, 1815–1822.Google Scholar
17. Aukes, AM, De Groot, JC, Wiegman, MJ, et al. Long-term cerebral imaging after pre-eclampsia. BJOG. 2012; 119, 1117–1122.Google Scholar
18. Hofmeyr, GJ, Belizan, JM, von Dadelszen, P, Calcium and Pre-eclampsia Study Group. Low-dose calcium supplementation for preventing pre-eclampsia: a systematic review and commentary. BJOG. 2014; 121, 951–957.CrossRefGoogle Scholar
19. Hofmeyr, GJ, Duley, L, Atallah, A. Dietary calcium supplementation for prevention of pre-eclampsia and related problems: a systematic review and commentary. BJOG. 2007; 114, 933–943.Google Scholar
20. Bergel, E, Barros, AJ. Effect of maternal calcium intake during pregnancy on children's blood pressure: a systematic review of the literature. BMC Pediatr. 2007; 7, 15.Google Scholar
21. Duley, L, Henderson-Smart, DJ, Meher, S, King, JF. Antiplatelet agents for preventing pre-eclampsia and its complications. Cochrane Database Syst Rev. 2007; CD004659.Google Scholar
22. Roberge, S, Nicolaides, KH, Demers, S, Villa, P, Bujold, E. Prevention of perinatal death and adverse perinatal outcome using low-dose aspirin: a meta-analysis. Ultrasound Obstet Gynecol. 2013; 41, 491–499.Google Scholar
23. Roberge, S, Giguere, Y, Villa, P, et al. Early administration of low-dose aspirin for the prevention of severe and mild preeclampsia: a systematic review and meta-analysis. Am J Perinatol. 2012; 29, 551–556.Google Scholar
24. Bujold, E, Roberge, S, Lacasse, Y, et al. Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy: a meta-analysis. Obstet Gynecol. 2010; 116, 402–414.Google Scholar
25. National Institute for Health and Clinical Excellence. Hypertension in pregnancy. NICE clinical guideline 107. 2011.Google Scholar
26. Magee, LA, Helewa, M, Moutquin, JM, von Dadelszen, P, Hypertension Guideline Committee; Strategic Training Initiative in Research in the Reproductive Health Sciences Scholars. Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy. J Obstet Gynaecol Can. 2008; 30, S1–48.CrossRefGoogle ScholarPubMed
27. Parazzini, F, Bortolus, R, Chatenoud, L, Restelli, S, Benedetto, C. Follow-up of children in the Italian Study of Aspirin in Pregnancy. Lancet. 1994; 343, 1235.Google Scholar
28. CLASP Collaborative Group. Low dose aspirin in pregnancy and early childhood development: follow up of the collaborative low dose aspirin study in pregnancy. CLASP collaborative group. Br J Obstet Gynaecol. 1995; 102, 861–868.Google Scholar
29. Marret, S, Marchand, L, Kaminski, M, et al. Group ES. Prenatal low-dose aspirin and neurobehavioral outcomes of children born very preterm. Pediatrics. 2010; 125, e29–34.Google Scholar
30. Hedley, AA, Ogden, CL, Johnson, CL, et al. Prevalence of overweight and obesity among US children, adolescents, and adults, 1999–2002. JAMA. 2004; 291, 2847–2850.CrossRefGoogle ScholarPubMed
31. Schokker, DF, Visscher, TL, Nooyens, AC, van Baak, MA, Seidell, JC. Prevalence of overweight and obesity in the Netherlands. Obes Rev. 2007; 8, 101–108.Google Scholar
32. Heslehurst, N, Ells, LJ, Simpson, H, et al. Trends in maternal obesity incidence rates, demographic predictors, and health inequalities in 36,821 women over a 15-year period. BJOG. 2007; 114, 187–194.CrossRefGoogle Scholar
33. Gaillard, R, Steegers, EA, Duijts, L, et al. Childhood cardiometabolic outcomes of maternal obesity during pregnancy: the Generation R Study. Hypertension. 2014; 63, 683–691.Google Scholar
34. Reynolds, RM, Allan, KM, Raja, EA, et al. Maternal obesity during pregnancy and premature mortality from cardiovascular event in adult offspring: follow-up of 1 323 275 person years. BMJ. 2013; 347, f4539.Google Scholar
35. Oben, JA, Mouralidarane, A, Samuelsson, AM, et al. Maternal obesity during pregnancy and lactation programs the development of offspring non-alcoholic fatty liver disease in mice. J Hepatol. 2010; 52, 913–920.Google Scholar
36. Nivoit, P, Morens, C, Van Assche, FA, et al. Established diet-induced obesity in female rats leads to offspring hyperphagia, adiposity and insulin resistance. Diabetologia. 2009; 52, 1133–1142.Google Scholar
37. Kirk, SL, Samuelsson, AM, Argenton, M, et al. Maternal obesity induced by diet in rats permanently influences central processes regulating food intake in offspring. PLoS One. 2009; 4, e5870.CrossRefGoogle ScholarPubMed
38. Thangaratinam, S, Rogozinska, E, Jolly, K, et al. Effects of interventions in pregnancy on maternal weight and obstetric outcomes: meta-analysis of randomised evidence. BMJ. 2012; 344, e2088.Google Scholar
39. Dodd, JM, Turnbull, D, McPhee, AJ, et al. Group LRT. Antenatal lifestyle advice for women who are overweight or obese: LIMIT randomised trial. BMJ. 2014; 348, g1285.Google Scholar
40. Painter, RC, Roseboom, TJ, Bleker, OP. Prenatal exposure to the Dutch famine and disease in later life: an overview. ReprodToxicol. 2005; 20, 345–352.Google Scholar
41. Group HSCR, Metzger, BE, Lowe, LP, et al. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med. 2008; 358, 1991–2002.Google Scholar
42. Franks, PW, Looker, HC, Kobes, S, et al. Gestational glucose tolerance and risk of type 2 diabetes in young Pima Indian offspring. Diabetes. 2006; 55, 460–465.Google Scholar
43. Rijpert, M, Evers, IM, de Vroede, MA, et al. Risk factors for childhood overweight in offspring of type 1 diabetic women with adequate glycemic control during pregnancy: nationwide follow-up study in the Netherlands. Diabetes Care. 2009; 32, 2099–2104.CrossRefGoogle ScholarPubMed
44. Group HSCR. Hyperglycaemia and Adverse Pregnancy Outcome (HAPO) Study: associations with maternal body mass index. BJOG. 2010; 117, 575–584.Google Scholar
45. Crowther, CA, Hiller, JE, Moss, JR, et al. Australian Carbohydrate Intolerance Study in Pregnant Women Trial G. Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. N Engl J Med. 2005; 352, 2477–2486.Google Scholar
46. Landon, MB, Spong, CY, Thom, E, et al. A multicenter, randomized trial of treatment for mild gestational diabetes. N Engl J Med. 2009; 361, 1339–1348.Google Scholar
47. Crowther, CA, Hague, WM, Middleton, PF et al. The IDEAL study: investigation of dietary advice and lifestyle for women with borderline gestational diabetes: a randomised controlled trial – study protocol. BMC Pregnancy Childbirth. 2012; 12, 106.Google Scholar
48. Pirc, LK, Owens, JA, Crowther, CA, et al. Mild gestational diabetes in pregnancy and the adipoinsular axis in babies born to mothers in the ACHOIS randomised controlled trial. BMC Pediatr. 2007; 7, 18.Google Scholar
49. Tita, AT, Landon, MB, Spong, CY, et al. Timing of elective repeat cesarean delivery at term and neonatal outcomes. N Engl J Med. 2009; 360, 111–120.Google Scholar
50. RCOG. Antenatal Corticosteroids to Reduce Neonatal Morbidity and Mortality, Green-Top Guideline No 7. 2010.Google Scholar
51. Stutchfield, P, Whitaker, R, Russell, I, Antenatal Steroids for Term Elective Caesarean Section Research T. Antenatal betamethasone and incidence of neonatal respiratory distress after elective caesarean section: pragmatic randomised trial. BMJ. 2005; 331, 662.Google Scholar
52. Sotiriadis, A, Makrydimas, G, Papatheodorou, S, Loannidis, JP. Corticosteroids for preventing neonatal respiratory morbidity after elective caesarean section at term. Cochrane Database Syst Rev. 2009; CD006614.Google Scholar
53. Moss, TJ, Sloboda, DM, Gurrin, LC, et al. Programming effects in sheep of prenatal growth restriction and glucocorticoid exposure. Am J Physiol Regul Integr Comp Physiol. 2001; 281, R960–970.Google Scholar
54. Nyirenda, MJ, Lindsay, RS, Kenyon, CJ, Burchell, A, Seckl, JR. Glucocorticoid exposure in late gestation permanently programs rat hepatic phosphoenolpyruvate carboxykinase and glucocorticoid receptor expression and causes glucose intolerance in adult offspring. J Clin Invest. 1998; 101, 2174–2181.Google Scholar
55. Drake, AJ, Raubenheimer, PJ, Kerrigan, D, et al. Prenatal dexamethasone programs expression of genes in liver and adipose tissue and increased hepatic lipid accumulation but not obesity on a high-fat diet. Endocrinology. 2010; 151, 1581–1587.Google Scholar
56. Dodic, M, Abouantoun, T, O'Connor, A, Wintour, EM, Moritz, KM. Programming effects of short prenatal exposure to dexamethasone in sheep. Hypertension. 2002; 40, 729–734.Google Scholar
57. Dickinson, H, Walker, DW, Wintour, EM, Moritz, K. Maternal dexamethasone treatment at midgestation reduces nephron number and alters renal gene expression in the fetal spiny mouse. Am J Physiol Regul Integr Comp Physiol. 2007; 292, R453–461.Google Scholar
58. de Vries, A, Holmes, MC, Heijnis, A, et al. Prenatal dexamethasone exposure induces changes in nonhuman primate offspring cardiometabolic and hypothalamic-pituitary-adrenal axis function. J Clin Invest. 2007; 117, 1058–1067.Google Scholar
59. Aghajafari, F, Murphy, K, Matthews, S, et al. Repeated doses of antenatal corticosteroids in animals: a systematic review. Am J Obstet Gynecol. 2002; 186, 843–849.Google Scholar
60. Dalziel, SR, Walker, NK, Parag, V, et al. Cardiovascular risk factors after antenatal exposure to betamethasone: 30-year follow-up of a randomised controlled trial. Lancet. 2005; 365, 1856–1862.Google Scholar
61. Stutchfield, PR, Whitaker, R, Gliddon, AE, et al. Behavioural, educational and respiratory outcomes of antenatal betamethasone for term caesarean section (ASTECS trial). Arch Dis Child Fetal Neonatal Ed. 2013; 98, F195–200.CrossRefGoogle ScholarPubMed
62. Niebyl, JR. Clinical practice. Nausea and vomiting in pregnancy. N Engl J Med. 2010; 363, 1544–1550.Google Scholar
63. Niemeijer, MN, Grooten, IJ, Vos, N, et al. Diagnostic markers for hyperemesis gravidarum: a systematic review and metaanalysis. Am J Obstet Gynecol. 2014; 211(150), e151–115.Google Scholar
64. Adams, MM, Harlass, FE, Sarno, AP, Read, JA, Rawlings, JS. Antenatal hospitalization among enlisted servicewomen, 1987–1990. Obstet Gynecol. 1994; 84, 35–39.Google Scholar
65. Gazmararian, JA, Petersen, R, Jamieson, DJ, et al. Hospitalizations during pregnancy among managed care enrollees. Obstet Gynecol. 2002; 100, 94–100.Google ScholarPubMed
66. Jewell, D, Young, G. Interventions for nausea and vomiting in early pregnancy. Cochrane Database Syst Rev. 2003; CD000145.Google Scholar
67. Veenendaal, MV, van Abeelen, AF, Painter, RC, van der Post, JA, Roseboom, TJ. Consequences of hyperemesis gravidarum for offspring: a systematic review and meta-analysis. BJOG. 2011; 118, 1302–1313.Google Scholar
68. Dodds, L, Fell, DB, Joseph, KS, Allen, VM, Butler, B. Outcomes of pregnancies complicated by hyperemesis gravidarum. Obstet Gynecol. 2006; 107, 285–292.Google Scholar
69. Grooten, I, Painter, R, Pontesilli, M, et al. Weight loss in pregnancy and cardiometabolic profile in childhood: findings from a longitudinal birth cohort. BJOG. 2014.Google Scholar
70. Bolin, M, Akerud, H, Cnattingius, S, Stephansson, O, Wikstrom, AK. Hyperemesis gravidarum and risks of placental dysfunction disorders: a population-based cohort study. BJOG. 2013; 120, 541–547.Google Scholar
71. Ayyavoo, A, Derraik, JG, Hofman, PL, Cutfield, WS. Hyperemesis gravidarum and long-term health of the offspring. Am J Obstet Gynecol. 2014; 210, 521–525.CrossRefGoogle ScholarPubMed
72. Farquhar, C, Rishworth, JR, Brown, J, Nelen, WL, Marjoribanks, J. Assisted reproductive technology: an overview of Cochrane Reviews. Cochrane Database Syst Rev. 2013; 8, CD010537.Google Scholar
73. Sazonova, A, Kallen, K, Thurin-Kjellberg, A, Wennerholm, UB, Bergh, C. Obstetric outcome after in vitro fertilization with single or double embryo transfer. HumReprod. 2011; 26, 442–450.Google Scholar
74. Helmerhorst, FM, Perquin, DA, Donker, D, Keirse, MJ. Perinatal outcome of singletons and twins after assisted conception: a systematic review of controlled studies. BMJ. 2004; 328, 261.Google Scholar
75. Sullivan, EA, Wang, YA, Norman, RJ, et al. Perinatal mortality following assisted reproductive technology treatment in Australia and New Zealand, a public health approach for international reporting of perinatal mortality. BMC Pregnancy Childbirth. 2013; 13, 177.Google Scholar
76. Dumoulin, JC, Land, JA, Van Montfoort, AP, et al. Effect of in vitro culture of human embryos on birthweight of newborns. Hum Reprod. 2010; 25, 605–612.Google Scholar
77. Watkins, AJ, Platt, D, Papenbrock, T, et al. Mouse embryo culture induces changes in postnatal phenotype including raised systolic blood pressure. Proc Natl Acad Sci USA. 2007; 104, 5449–5454.Google Scholar
78. Rexhaj, E, Paoloni-Giacobino, A, Rimoldi, SF, et al. Mice generated by in vitro fertilization exhibit vascular dysfunction and shortened life span. J Clin Invest. 2013; 123, 5052–5060.Google Scholar
79. Rerat, M, Zbinden, Y, Saner, R, Hammon, H, Blum, JW. In vitro embryo production: growth performance, feed efficiency, and hematological, metabolic, and endocrine status in calves. J Dairy Sci. 2005; 88, 2579–2593.Google Scholar
80. Ertzeid, G, Storeng, R. Adverse effects of gonadotrophin treatment on pre- and postimplantation development in mice. J Reprod Fertil. 1992; 96, 649–655.Google Scholar
81. Braakhekke, M, Kamphuis, EI, van Rumste, MM, et al. How are neonatal and maternal outcomes reported in randomised controlled trials (RCTs) in reproductive medicine? Hum Reprod. 2014; 29, 1211–1217.Google Scholar
82. Davies, MJ, Moore, VM, Willson, KJ, et al. Reproductive technologies and the risk of birth defects. N Engl J Med. 2012; 366, 1803–1813.Google Scholar
83. Ceelen, M, van Weissenbruch, MM, Vermeiden, JP, van Leeuwen, FE, D-vdW, HA. Cardiometabolic differences in children born after in vitro fertilization: follow-up study. J Clin Endocrinol Metab. 2008; 93, 1682–1688.Google Scholar
84. Belva, F, Henriet, S, Liebaers, I, et al. Medical outcome of 8-year-old singleton ICSI children (born >or=32 weeks' gestation) and a spontaneously conceived comparison group. Hum Reprod. 2007; 22, 506–515.Google Scholar
85. Scherrer, U, Rimoldi, SF, Rexhaj, E, et al. Systemic and pulmonary vascular dysfunction in children conceived by assisted reproductive technologies. Circulation. 2012; 125, 1890–1896.Google Scholar
86. Valenzuela-Alcaraz, B, Crispi, F, Bijnens, B, et al. Assisted reproductive technologies are associated with cardiovascular remodeling in utero that persists postnatally. Circulation. 2013; 128, 1442–1450.Google Scholar
87. Ceelen, M, van Weissenbruch, MM, Roos, JC, Vermeiden, JP, van Leeuwen, FE, D-vdW, HA. Body composition in children and adolescents born after in vitro fertilization or spontaneous conception. J Clin Endocrinol Metab. 2007; 92, 3417–3423.Google Scholar
88. Belva, F, Painter, RC, Schiettecatte, J, et al. Gender-specific alterations in salivary cortisol levels in pubertal intracytoplasmic sperm injection offspring. Horm Res Paediatr. 2013; 80, 350–355.CrossRefGoogle ScholarPubMed
89. Sakka, SD, Malamitsi-Puchner, A, Loutradis, D, Chrousos, GP, Kanaka-Gantenbein, C. Euthyroid hyperthyrotropinemia in children born after in vitro fertilization. J Clin Endocrinol Metab. 2009; 94, 1338–1341.Google Scholar
90. Brandes, M, Hamilton, CJ, van der Steen, JO, et al. Unexplained infertility: overall ongoing pregnancy rate and mode of conception. Hum Reprod. 2011; 26, 360–368.Google Scholar